Essa Bancorp Inc. (ESSA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
ESSA Bancorp, Inc. Declares Quarterly Dividend
STROUDSBURG, PA / ACCESSWIRE / August 28, 2024 / ESSA Bancorp, Inc. (NASDAQ Global MarketSM:ESSA), the holding company for ESSA Bank & Trust, today announced that its Board of Directors declared a dividend of fifteen cents ($0.15) per share. The dividend is payable to shareholders of record as of September 16, 2024, payable on September 30, 2024.
Essa Bancorp (ESSA) Lags Q3 Earnings and Revenue Estimates
Essa Bancorp (ESSA) came out with quarterly earnings of $0.41 per share, missing the Zacks Consensus Estimate of $0.45 per share. This compares to earnings of $0.45 per share a year ago.
Essa Bancorp (ESSA) Moves 5.4% Higher: Will This Strength Last?
Essa Bancorp (ESSA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ESSA Pharma's Speculative Buy Potential: Masofaniten Promise For Prostate Cancer
ESSA Pharma Inc. is developing Masofaniten, a drug that disrupts the androgen receptor to stop prostate cancer growth, with promising results in phase 1 trials. Masofaniten has the potential to overcome resistance to other standard-of-care treatments, offering a more effective option for patients with resistant prostate cancer. The market opportunity for Masofaniten is substantial, with the antiandrogen therapy market generating approximately $9 billion in 2022.
